Subscribe for $2

Subscribe for 2 $

Financial Data API

Terminal Financial Data API

Affimed Aktie News & Pressemeldungen

Affimed Eulerpool News

12/6/2024, 11:42:05 AM

FDA stärkt Hoffnung für Patient:innen mit fortgeschrittener Lymphomtherapie

1

1

Affimed Stock News

Affimed is being monitored by journalists and investors worldwide. We gather the latest Affimed news here.

December 17 ·
Yahoo
Affimed Reports Positive Clinical Update on AFM24/Atezolizumab Combination Therapy in Non-Small Cell Lung Cancer (NSCLC)
December 9 ·
Yahoo
Affimed to Host Investor Conference Call Highlighting Clinical Data from AFM24 in Combination with Atezolizumab in Non-Small Cell Lung Cancer
December 8 ·
Yahoo
Affimed Announces Positive Results Demonstrating Safety and Efficacy of Acimtamig and AlloNK® Combination in Relapsed/Refractory Classical Hodgkin Lymphoma (R/R cHL) Patients
December 6 ·
Yahoo
FDA ARMAT status for Affimed and Artiva’s lymphoma combo therapy
December 5 ·
Yahoo
Affimed Announces Acimtamig and AlloNK® Combination Granted Regenerative Medicine Advanced Therapy (RMAT) Designation by the U.S. Food and Drug Administration (FDA)
November 15 ·
Yahoo
Affimed NV (AFMD) Q3 2024 Earnings Call Highlights: Navigating Financial Challenges with ...
November 14 ·
SeekingAlpha
Affimed N.V. (AFMD) Q3 2024 Earnings Call Transcript
November 14 ·
Yahoo
Affimed N.V.: Q3 Earnings Snapshot
November 14 ·
Yahoo
Affimed Reports Third Quarter 2024 Financial Results & Business Update
November 14 ·
SeekingAlpha
Affimed N.V. 2024 Q3 - Results - Earnings Call Presentation

1

2

1

2

Affimed Stock Press Releases

Affimed regularly publishes news on the company's website that are relevant for investors.

Access the world's leading financial data and tools

Subscribe for $2